Literature DB >> 22961700

LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma.

Feng Yao1, Tiejun Zhao, Chenxi Zhong, Ji Zhu, Heng Zhao.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most common lethal tumors in the world, and the development of new therapeutic targets is needed. Recent studies have shown that aerobic glycolysis, also known as the Warburg effect, mediated the anti-apoptotic effects in cancer cells. Lactate dehydrogenase A (LDHA) which executed the final step of aerobic lactate production has been reported to be involved in the tumor progression. However, the function of LDHA in ESCC has not been investigated. In this study, it was found that LDHA was up-regulated in ESCC clinical samples. Knockdown of the expression of LDHA inhibited cell growth and cell migration in vitro as well as tumorigenesis in vivo. With regard to the molecular mechanism, silencing the expression of LDHA was related to decreased AKT activation and cyclin D1 expression and increased cleavage of PARP and caspase 8. Taken together, our findings suggest that LDHA plays an important role in the progression of ESCC by modulating cell growth, and LDHA might be a potential therapeutic target in ESCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22961700     DOI: 10.1007/s13277-012-0506-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

1.  Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene.

Authors:  B C Lewis; H Shim; Q Li; C S Wu; L A Lee; A Maity; C V Dang
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

Authors:  H Shim; C Dolde; B C Lewis; C S Wu; G Dang; R A Jungmann; R Dalla-Favera; C V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

4.  Identification of a gene-expression signature for predicting lymph node metastasis in patients with early stage cervical carcinoma.

Authors:  Long Huang; Min Zheng; Qing-Min Zhou; Mei-Ying Zhang; Wei-Hua Jia; Jing-Ping Yun; Hui-Yun Wang
Journal:  Cancer       Date:  2011-02-11       Impact factor: 6.860

5.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.

Authors:  Valeria R Fantin; Julie St-Pierre; Philip Leder
Journal:  Cancer Cell       Date:  2006-06       Impact factor: 31.743

6.  A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism.

Authors:  Zhen Cai; Jiang-Sha Zhao; Jing-Jing Li; Dan-Ni Peng; Xiao-Yan Wang; Tian-Lu Chen; Yun-Ping Qiu; Ping-Ping Chen; Wen-Jie Li; Li-Yan Xu; En-Ming Li; Jason P M Tam; Robert Z Qi; Wei Jia; Dong Xie
Journal:  Mol Cell Proteomics       Date:  2010-08-10       Impact factor: 5.911

Review 7.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

8.  Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.

Authors:  Yue-Zhen Deng; Ping-Ping Chen; Yan Wang; Dong Yin; H Phillip Koeffler; Baojie Li; Xiang-Jun Tong; Dong Xie
Journal:  J Biol Chem       Date:  2007-10-21       Impact factor: 5.157

9.  Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions.

Authors:  Johnathan C Maher; Awtar Krishan; Theodore J Lampidis
Journal:  Cancer Chemother Pharmacol       Date:  2003-11-07       Impact factor: 3.333

10.  Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma.

Authors:  Zhu-Qing Zhou; Wei-Hua Cao; Jian-Jun Xie; Jing Lin; Zhong-Ying Shen; Qing-Ying Zhang; Jin-Hui Shen; Li-Yan Xu; En-Min Li
Journal:  BMC Cancer       Date:  2009-08-22       Impact factor: 4.430

View more
  47 in total

Review 1.  Targeting Cancer Metabolism and Current Anti-Cancer Drugs.

Authors:  Witchuda Sukjoi; Jarunya Ngamkham; Paul V Attwood; Sarawut Jitrapakdee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Small-molecule inhibitors of human LDH5.

Authors:  Carlotta Granchi; Ilaria Paterni; Reshma Rani; Filippo Minutolo
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

3.  Screening of novel inhibitors targeting lactate dehydrogenase A via four molecular docking strategies and dynamics simulations.

Authors:  Rong Sun; Xin Li; Yuanyuan Li; Xun Zhang; Xinru Li; Xiaoyu Li; Zheng Shi; Jinku Bao
Journal:  J Mol Model       Date:  2015-05-02       Impact factor: 1.810

4.  Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.

Authors:  Nzinga Mack; Elizabeth A Mazzio; David Bauer; Hernan Flores-Rozas; Karam F A Soliman
Journal:  Anticancer Res       Date:  2017-03       Impact factor: 2.480

5.  Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).

Authors:  Ganesha Rai; Kyle R Brimacombe; Bryan T Mott; Daniel J Urban; Xin Hu; Shyh-Ming Yang; Tobie D Lee; Dorian M Cheff; Jennifer Kouznetsova; Gloria A Benavides; Katie Pohida; Eric J Kuenstner; Diane K Luci; Christine M Lukacs; Douglas R Davies; David M Dranow; Hu Zhu; Gary Sulikowski; William J Moore; Gordon M Stott; Andrew J Flint; Matthew D Hall; Victor M Darley-Usmar; Leonard M Neckers; Chi V Dang; Alex G Waterson; Anton Simeonov; Ajit Jadhav; David J Maloney
Journal:  J Med Chem       Date:  2017-11-09       Impact factor: 7.446

6.  Silencing LDHA inhibits proliferation, induces apoptosis and increases chemosensitivity to temozolomide in glioma cells.

Authors:  Hui Di; Xinting Zhang; Yi Guo; Yanfang Shi; Chuan Fang; Yu Yuan; Jiwei Wang; Chao Shang; Wenzhe Guo; Chunhui Li
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

7.  Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.

Authors:  Xuren Sun; Zhe Sun; Zhi Zhu; Chenyan Li; Junyan Zhang; Huimian Xu; Mingjun Sun
Journal:  Tumour Biol       Date:  2015-04-26

8.  Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype.

Authors:  Tajindra Singh Saluja; Anita Spadigam; Anita Dhupar; Shaheen Syed
Journal:  Tumour Biol       Date:  2015-11-15

9.  Lactate dehydrogenase A silencing in IDH mutant gliomas.

Authors:  Charles Chesnelong; Myriam M Chaumeil; Michael D Blough; Mohammad Al-Najjar; Owen D Stechishin; Jennifer A Chan; Russell O Pieper; Sabrina M Ronen; Samuel Weiss; H Artee Luchman; J Gregory Cairncross
Journal:  Neuro Oncol       Date:  2013-12-22       Impact factor: 12.300

10.  Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis.

Authors:  Peng Fei Liu; Yan Wei Cao; Hai Ping Jiang; Yong Hua Wang; Xue Cheng Yang; Xin Sheng Wang; Hai Tao Niu
Journal:  Med Oncol       Date:  2014-08-02       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.